Company intelligence / Profile preview

Mass General Brigham Ventures

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Mass General Brigham Ventures is a venture capital firm associated with Mass General Brigham, managing approximately $450 million across three funds. It focuses on life science and healthcare innovation, making early-stage investments and has realized 20 exits including 8 IPOs and 12 M&As. It also operates an Artificial Intelligence and Digital Innovation Fund (AIDIF).

Industry: Investors

Partnerships

Harvard Medical SchoolRocheNovartisAstraZenecaEli LillyMerckSanofi

Beyond the preview

Go deeper on Mass General Brigham Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mass General Brigham Ventures.

Explore the full profile